Medicare Enrolled
Dr. Luke Dreisbach, M.D.
Hematology & Oncology · Rancho Mirage, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dreisbach from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dreisbach?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dreisbach
Dr. Luke Dreisbach is a hematology & oncology specialist in Rancho Mirage, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dreisbach performed 824,645 Medicare services across 9,618 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dreisbach received a total of $19,741 from 98 pharmaceutical and/or device companies across 1080 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dreisbach is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 0% volume in CA
$19,741 industry payments
Medicare Practice Summary
Medicare Utilization ↗824,645
Medicare services
Top 0% in CA for hematology & oncology
9,618
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~43,402 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
249,750 | $1 | $3 |
| Levoleucovorin injection, 0.5 mg An injection of levoleucovorin, a form of folate, administered in a 0.5 mg dose. |
118,300 | $0 | $1 |
| Pembrolizumab injection (Keytruda) | 84,506 | $43 | $139 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
65,850 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 45,000 | $18 | $59 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
30,240 | $6 | $21 |
| Paclitaxel protein-bound particle injection An injection of paclitaxel formulated as protein-bound particles. This code specifies the administration of the medication measured in milligrams. |
29,800 | $10 | $33 |
| Nivolumab injection (Opdivo) | 26,100 | $24 | $77 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
25,920 | $38 | $119 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
18,700 | $0 | $0 |
| Injection, atezolizumab, 10 mg | 13,608 | $64 | $206 |
| Injection, heparin sodium, (heparin lock flush), per 10 units | 12,600 | $0 | $0 |
| Bevacizumab-bvzr biosimilar injection, 10 mg An injection of bevacizumab-bvzr, a biosimilar medication, administered in a 10 mg dose. |
12,590 | $23 | $143 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
10,150 | $35 | $117 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
9,931 | $0 | $0 |
| Injection, docetaxel, 1 mg | 9,186 | $1 | $2 |
| Anti-nausea injection (Aloxi/palonosetron) | 5,880 | $1 | $7 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
4,949 | $8 | $25 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
4,730 | $23 | $161 |
| Injection, atropine sulfate, 0.01 mg | 3,400 | $0 | $0 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
3,384 | $92 | $842 |
| Injection, granisetron hydrochloride, 100 mcg | 3,270 | $0 | $1 |
| Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg | 3,085 | $4 | $18 |
| Injection, fulvestrant, 25 mg | 2,820 | $8 | $111 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,693 | $8 | $18 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
2,661 | $13 | $45 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,461 | $102 | $337 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
2,237 | $10 | $55 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,794 | $12 | $37 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
1,711 | $2 | $6 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
1,523 | $113 | $390 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
1,279 | $11 | $36 |
| Injection, irinotecan, 20 mg | 1,233 | $2 | $7 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
1,010 | $2 | $6 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 841 | $3 | $10 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
725 | $2 | $6 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
713 | $0 | $2 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
662 | $69 | $238 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
647 | $55 | $194 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
627 | $56 | $189 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
597 | $25 | $83 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
563 | $6 | $15 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
556 | $1 | $3 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 474 | $134 | $510 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
473 | $24 | $82 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
406 | $29 | $88 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
404 | $2 | $10 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
392 | $1 | $2 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
384 | $143 | $470 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
358 | $63 | $217 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
321 | $18 | $58 |
| New patient office visit, complex (60-74 min) | 307 | $167 | $573 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
306 | $66 | $196 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
231 | $7 | $20 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
211 | $48 | $163 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
207 | $6 | $28 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
189 | $1 | $20 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
185 | $21 | $76 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
178 | $56 | $141 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
176 | $147 | $300 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
170 | $99 | $293 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
168 | $27 | $95 |
| Injection, furosemide, up to 20 mg | 159 | $0 | $2 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
149 | $1 | $7 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
107 | $1 | $5 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
82 | $58 | $238 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
77 | $8 | $45 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
73 | $72 | $286 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
31 | $32 | $110 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $47 | $147 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
28 | $144 | $518 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
26 | $70 | $338 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
18 | $150 | $474 |
| Routine 12-lead electrocardiogram (ECG) A test that records the electrical activity of the heart using at least 12 leads to produce a tracing. |
15 | $6 | $17 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $140 | $434 |
| Intravenous chemotherapy injection Chemotherapy medication is administered directly into a vein using a push technique. This method involves injecting the drug through a needle or catheter already placed in the vein. |
13 | $88 | $299 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
32.1% high complexity
65.7% medium
2.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,741
Total received (2018-2024)
Avg $2,820/year across 7 years
Top 21% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
98
Companies
1,080
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,706 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$35 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,581
2023
$3,372
2022
$3,208
2021
$2,678
2020
$2,279
2019
$2,536
2018
$2,088
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$283
AstraZeneca Pharmaceuticals LP
$254
Novartis Pharmaceuticals Corporation
$239
Janssen Biotech, Inc.
$178
E.R. Squibb & Sons, L.L.C.
$177
BeiGene USA, Inc.
$163
Daiichi Sankyo Inc.
$152
GlaxoSmithKline, LLC.
$136
Regeneron Healthcare Solutions, Inc.
$126
Gilead Sciences, Inc.
$118
Astellas Pharma US Inc
$117
Celgene Corporation
$114
Merck Sharp & Dohme LLC
$104
ABBVIE INC.
$100
Tempus AI, Inc
$94
Genentech USA, Inc.
$87
SOBI, INC
$79
ARRAY BIOPHARMA INC
$78
Incyte Corporation
$75
GENZYME CORPORATION
$75
Takeda Pharmaceuticals U.S.A., Inc.
$66
Kite Pharma, Inc.
$63
Genmab U.S., Inc.
$58
Eisai Inc.
$54
Boehringer Ingelheim Pharmaceuticals, Inc.
$53
Deciphera Pharmaceuticals Inc.
$53
Stemline Therapeutics Inc.
$49
Dendreon Pharmaceuticals LLC
$35
Rigel Pharmaceuticals, Inc.
$34
PharmaEssentia USA Corporation
$34
Ipsen Biopharmaceuticals, Inc
$34
Karyopharm Therapeutics Inc.
$34
Blueprint Medicines Corporation
$29
Coherus Biosciences Inc.
$25
PUMA BIOTECHNOLOGY, INC.
$23
Bayer Healthcare Pharmaceuticals Inc.
$23
SpringWorks Therapeutics, Inc.
$22
JAZZ PHARMACEUTICALS INC.
$21
EMD Serono, Inc.
$20
Agios Pharmaceuticals, Inc.
$20
RECORDATI_RARE_DISEASES_INC.
$19
Kyowa Kirin, Inc.
$17
Sumitomo Pharma America, Inc.
$17
Mirati Therapeutics, Inc.
$14
Lilly USA, LLC
$14
Top 3 companies account for 21.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,920
AstraZeneca Pharmaceuticals LP
$1,735
E.R. Squibb & Sons, L.L.C.
$1,160
PFIZER INC.
$1,040
Janssen Biotech, Inc.
$856
Astellas Pharma US Inc
$717
Amgen Inc.
$688
Genentech USA, Inc.
$650
GlaxoSmithKline, LLC.
$521
BeiGene USA, Inc.
$494
Merck Sharp & Dohme Corporation
$476
Gilead Sciences, Inc.
$463
Seagen Inc.
$460
Merck Sharp & Dohme LLC
$383
Celgene Corporation
$352
Coherus Biosciences Inc.
$335
Daiichi Sankyo Inc.
$324
Pharmacyclics LLC, An AbbVie Company
$308
GENZYME CORPORATION
$300
Incyte Corporation
$280
Regeneron Healthcare Solutions, Inc.
$245
Puma Biotechnology, Inc.
$218
Ipsen Biopharmaceuticals, Inc
$207
Boehringer Ingelheim Pharmaceuticals, Inc.
$204
Takeda Pharmaceuticals U.S.A., Inc.
$198
AbbVie Inc.
$198
EISAI INC.
$197
ARRAY BIOPHARMA INC
$189
Karyopharm Therapeutics Inc.
$185
EMD Serono, Inc.
$185
Kite Pharma, Inc.
$173
Rigel Pharmaceuticals, Inc.
$170
Teva Pharmaceuticals USA, Inc.
$168
ABBVIE INC.
$163
Galvanize Therapeutics, Inc
$158
Octapharma USA, Inc.
$157
Pharmacyclics LLC, an AbbVie Company
$137
Bayer HealthCare Pharmaceuticals Inc.
$129
SOBI, INC
$126
Blueprint Medicines Corporation
$121
Aurobindo Pharma USA, Inc.
$119
PUMA BIOTECHNOLOGY, INC.
$111
Eisai Inc.
$105
Deciphera Pharmaceuticals Inc.
$103
Foundation Medicine, Inc.
$101
Verity Pharmaceuticals Inc.
$95
Tempus AI, Inc
$94
Seattle Genetics, Inc.
$93
Alexion Pharmaceuticals, Inc.
$89
Bayer Healthcare Pharmaceuticals Inc.
$78
Stemline Therapeutics Inc.
$73
Sobi, Inc
$70
TerSera Therapeutics LLC
$69
AVEO Pharmaceuticals, Inc.
$68
Secura Bio, Inc.
$64
Epizyme, Inc.,
$64
Lilly USA, LLC
$60
Genmab U.S., Inc.
$58
TOLMAR Pharmaceuticals, Inc.
$57
Mirati Therapeutics, Inc.
$57
Spectrum Pharmaceuticals Inc.
$54
Dova Pharmaceuticals
$54
Sun Pharmaceutical Industries Inc.
$52
Adaptive Biotechnologies Corporation
$52
JAZZ PHARMACEUTICALS INC.
$51
MorphoSys, US Inc.
$50
Sumitomo Pharma America, Inc.
$49
Acceleron Pharma, Inc.
$44
Pharmacosmos Therapeutics Inc.
$43
Exelixis Inc.
$39
Jazz Pharmaceuticals Inc.
$39
AbbVie, Inc.
$38
Dendreon Pharmaceuticals LLC
$35
PharmaEssentia USA Corporation
$34
Sirtex Medical Inc
$34
EUSA Pharma (US) LLC
$34
Kyowa Kirin, Inc.
$33
ImmunoGen, Inc.
$28
CTI BioPharma Corp.
$26
Chiesi USA, Inc.
$26
TG THERAPEUTICS, INC.
$25
TESARO, Inc.
$23
Blue Earth Diagnostics Limited
$23
SpringWorks Therapeutics, Inc.
$22
Array BioPharma Inc.
$22
Agios Pharmaceuticals, Inc.
$20
RECORDATI_RARE_DISEASES_INC.
$19
Partner Therapeutics, Inc.
$18
Abbott Laboratories
$18
Heron Therapeutics, Inc.
$18
AMAG Pharmaceuticals, Inc.
$18
APO-PHARMA USA, INC.
$15
Myriad Genetic Laboratories, Inc.
$15
Novocure Inc.
$14
CSL Behring
$12
Helsinn Therapeutics (U.S.), Inc.
$12
Clovis Oncology, Inc.
$11
Janssen Pharmaceuticals, Inc
$6
Top 3 companies account for 24.4% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALIYA SYSTEM · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · BYNFEZIA PEN · Balversa · Bavencio · Beleodaq · Blincyto · Braftovi · CALQUENCE · CARVYKTI · CELL-DYN Ruby · CHANTIX · CYRAMZA · Cabometyx · Columvi · DARZALEX · DEFERIPRONE · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · EXKIVITY · Elahere · Enhertu · Epkinly · Erleada · FARYDAK · FASLODEX · FERAHEME · FERRIPROX · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Farydak · Folotyn · GAVRETO · GAZYVA · GILOTRIF · Gazyva · HEMLIBRA · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INFUGEM · INJECTAFER · INLYTA · Idelvion · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lunsumio · MAVYRET · MEKINIST · MONJUVI · MONOFERRIC · MYCHOICE CDX · MYLOTARG · NERLYNX · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Onivyde · Optune · Orserdu · PADCEV · PIQRAY · PLUVICTO · POSLUMA · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pomalyst · Poteligeo · QINLOCK · Quzyttir · REBLOZYL · ROLVEDON · RUXIENCE · RYDAPT · Reblozyl · Rezlidhia · Rituxan · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUSTOL · SUTENT · SYLVANT · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Trelstar · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · Vyloy · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · XYNTHA · Xermelo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYKADIA · ZYTIGA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
17
Per 100K population
0.7
County median income
$89,672
Nearest hospital
EISENHOWER MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dreisbach is a mixed practice specialist, with above-average Medicare volume (top 0% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dreisbach experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Dreisbach performed 249,750 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dreisbach receive payments from pharmaceutical companies?
Yes. Dr. Dreisbach received a total of $19,741 from 98 companies across 1,080 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dreisbach's costs compare to other hematology & oncology specialists in Rancho Mirage?
Dr. Dreisbach's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dreisbach) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Rancho Mirage
Browse hematology & oncology specialists in Rancho Mirage ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology